Medicine guide

Ocrevus

As listed in the register: Ocrevus, Konzentrat zur Herstellung einer Infusionslösung

·

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Ocrelizumabum
Made by
Roche Pharma (Schweiz) AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Behandlung von erwachsenen Patienten mit aktiven schubförmigen Verlaufsformen der Multiplen Sklerose (MS) oder mit primär progredienter Multipler Sklerose (PPMS). Behandlung pädiatrischer Patienten ab einem Alter von 12 Jahren mit aktiver schubförmig remittierender Multipler Sklerose (RRMS).

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byRoche Pharma (Schweiz) AG
Active substanceOcrelizumabum
Used inCancer treatments and immune-system medicines
ClassificationL04AG08 · Cancer treatments and immune-system medicines
Dispensing (as stated by the register)Abgabekategorie A
Name in the registerOcrevus, Konzentrat zur Herstellung einer Infusionslösung
Packs1 Durchstechflasche(n)
Zulassungsnummer66185
Dosisstärke1

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.